Hengrui Pharmaceutical announced that on August 13, the company repurchased 405,000 A-shares for employee stock ownership plans, accounting for 0.006% of the shares already issued prior to the incident. The repurchase price per share ranged from $53.75 to $54.27, with a total payment price of $21,862,650. As of August 13, the total number of issued shares was 6,368,059,024 shares, and the treasury shares were 10,943,250 shares.

Hengrui Pharmaceutical announced that on August 13, the company repurchased 405,000 A-shares for employee stock ownership plans, accounting for 0.006% of the shares already issued prior to the incident. The repurchase price per share ranged from $53.75 to $54.27, with a total payment price of $21,862,650. As of August 13, the total number of issued shares was 6,368,059,024 shares, and the treasury shares were 10,943,250 shares.